SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-09-001385
Filing Date
2009-11-06
Accepted
2009-11-06 09:14:15
Documents
8
Period of Report
2009-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 14482
2 NOTICE AND MANAGEMENT PROXY CIRCULAR ex991.htm EX-99.1 563499
3 FORM OF PROXY ex992.htm EX-99.2 1300
4 OFFICER'S CERTIFICATE ex993.htm EX-99.3 9749
5 GRAPHIC loruslogo.jpg GRAPHIC 16389
6 GRAPHIC pg.jpg GRAPHIC 55699
7 GRAPHIC proxy1.jpg GRAPHIC 340727
8 GRAPHIC proxy2.jpg GRAPHIC 309986
  Complete submission text file 0001279569-09-001385.txt   1587064
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 091162923
SIC: 2836 Biological Products, (No Diagnostic Substances)